tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Income Statement

Compare
2 Followers

CStone Pharmaceuticals Income Statement

Last quarter (Q4 2024), CStone Pharmaceuticals's total revenue was ¥76.52M, a decrease of -24.38% from the same quarter last year. In Q4, CStone Pharmaceuticals's net income was ¥-53.45M. See CStone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 407.20M¥ 463.84M¥ 481.36M¥ 243.72M¥ 1.04B
Gross Profit
¥ 240.15M¥ 304.30M¥ 278.38M¥ 136.89M¥ 797.41M
Operating Expenses
¥ 331.85M¥ 304.30M¥ 1.18B¥ 1.93B¥ 1.86B
Depreciation and Amortization
¥ 18.93M¥ 58.19M¥ 44.54M¥ 22.66M¥ 14.80M
EBITDA
¥ -76.43M¥ -297.23M¥ -849.66M¥ -1.90B¥ -1.20B
Operating Income
¥ -91.69M¥ -534.61M¥ -832.27M¥ -1.85B¥ -1.22B
Other Income/Expenses
¥ 485.00K¥ 167.37M¥ 9.47M¥ -90.66M¥ -129.07M
Pretax Income
¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B¥ -1.22B
Net Income
¥ -91.21M¥ -367.23M¥ -964.61M¥ -1.99B¥ -1.22B
Per Share Metrics
Basic EPS
¥ -0.07¥ -0.29¥ -0.82¥ -1.71¥ -1.17
Diluted EPS
¥ -0.07¥ -0.29¥ -0.82¥ -1.71¥ -1.17
Weighted Average Shares Outstanding
1.28B 1.26B 1.17B 1.16B 1.04B
Weighted Average Shares Outstanding (Diluted)
1.28B 1.26B 1.17B 1.17B 1.05B
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis